Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Mã công tyHLN
Tên công tyHaleon PLC
Ngày IPOJul 18, 2022
Được thành lập vào2021
CEOMr. Brian Mcnamara
Số lượng nhân viên- -
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhJul 18
Địa chỉBuilding 5, First Floor
Thành phốWEYBRIDGE
Sàn giao dịch chứng khoánLondon Stock Exchange
Quốc giaUnited Kingdom
Mã bưu điệnKT13 0NY
Điện thoại441932822000
Trang webhttps://www.haleon.com/
Mã công tyHLN
Ngày IPOJul 18, 2022
Được thành lập vào2021
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023